We structure
biomedical platforms
that create real impact
in Latin America.
A Mexico-based strategic advisory boutique that helps healthcare and life sciences organizations navigate complexity, reduce risk, and build scalable, differentiated platforms.
Science. Strategy. Impact.
We connect the critical dots.
Science, regulation, operations, and strategy rarely speak the same language. We bring them together to design viable, compliant and commercially successful biomedical solutions.
Science & Innovation
Regulatory & Access
Operations & Infrastructure
Commercial & Market Strategy
Partnerships & Investment
Biomedical projects fail when science, regulation, operations and business are not aligned.
Many health innovation projects start with strong science or clinical enthusiasm, but fail because claims are unclear, documentation is weak, regulatory pathways are undefined, operational assumptions are unrealistic, or the business case is not defensible.
Advisory built for the complexity of regulated biomedical work.
Advanced Health Platforms
Advanced therapies, regenerative medicine and translational platforms with clinical and scientific rigor.
Medical Devices & MedTech
Strategy for medical systems and procedural platforms. Quality, regulatory (ISO 13485), and go-to-market readiness.
Biomedical Infrastructure & GMP
GMP/BPF laboratories and operational architecture. Validation, quality systems, documentation and flows.
Healthcare Ecosystems
Integrated care, recovery and longevity models. Cross-border patient experience and wellness platforms.
Strategic Positioning & Commercialization
Evidence-based positioning, medical storytelling, clinical adoption strategy and investor communication.
Health Ecosystems & Destinations
Strategic development of healthcare ecosystems, patient experience infrastructure and destination positioning for high-value health services.
Why Axiom Biostrategy is different.
Complementary Specialization
We integrate highly specialized perspectives to solve complex challenges that require multidisciplinary convergence.
Translational Business Thinking
We translate scientific and regulatory complexity into commercial and operational advantage.
Structure Before Scale
We build the right foundation to reduce risk, optimize resources, and prepare for scale.
Platform Oriented
We design platforms, not isolated projects. Sustainable by design. Built for long-term impact.
A clear path from idea to decision-ready execution.
Our work helps leadership teams understand what should be built, what should not be promised, what must be documented and which risks must be controlled before committing capital.
Define the opportunity and strategic thesis
Map technical, clinical, regulatory and operational risk
Design the service, facility or platform model on paper
Build the business case and execution roadmap
Prepare leadership-ready documentation for decision-making
Documentation that helps leadership decide.
Every engagement produces structured, board-ready deliverables — not slide decks, but defensible strategic documents built to withstand technical, regulatory and business scrutiny.
Built for the organizations shaping health innovation.
Private Hospitals & Clinic Groups
Building differentiated services and new revenue lines.
Biotech & Health Innovation Companies
From concept to market with regulatory and commercial clarity.
Medical Device Manufacturers
Strategy, compliance and market access for sustainable growth.
Investors & Strategic Partners
Due diligence, market assessment and platform viability.
Government & Institutions
Policy, access strategies and public-private collaboration.
Strategy with scientific depth, regulatory discipline and business clarity.
A senior team built around science, operations, regulatory strategy and institutional execution.
Axiom combines biomedical depth, laboratory implementation experience, regulatory strategy, clinical trial perspective and government-affairs insight to help clients build projects that can withstand technical, regulatory, institutional and business scrutiny.
Juan Pablo Aguilar Alemán, PhD
Biomedical Strategy & Scientific Structuring
Biomedical engineer and translational strategist with deep expertise in advanced therapies, biomaterials, medical devices, technology transfer, regulated product development, QMS architecture, GMP-readiness, risk analysis and biomedical business case design.
Miguel Ángel Ramírez Amezcua, BSc
Operations, Laboratory Build-Out & Scale-Up
Biochemical engineer and biomedical operations specialist with hands-on experience in laboratory construction, operational scale-up, supplier coordination, workflow design, quality systems and the professionalization of cell therapy and biomedical laboratory platforms.
Roberto García Galaviz, MD, MBA
Regulatory Strategy, Clinical Trials & Government Affairs
Physician and business strategist with expertise in regulatory pathways, clinical trial design, institutional relations and government affairs for biomedical and health innovation projects — bringing policy, stakeholder-management and market-access perspective.
"Axiom Biostrategy is not a generic advisory firm. It is designed for biomedical projects where the cost of poor definition is high."
Unclear claims, weak documentation, unrealistic implementation, unfunded operations or regulatory exposure — we eliminate these risks before they become costly.
Build the project
before you build
the facility.
Start with a structured strategic engagement to define the business, technical, regulatory and operational foundation of your biomedical project.